Edinburgh Molecular Imaging Commences Phase II European Cancer Trial
September 20, 2017
Novel Compound with Potential for Early Detection and to Guide Treatment of Colorectal Cancer Edinburgh, UK, September 20, 2017 – Edinburgh Molecular Imaging (EM Imaging),